BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6433802)

  • 41. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].
    Ohyama M; Matsumura M; Katsuta K; Nobori T; Matsuyama H; Fukami K; Kiyota R; Yano H; Shima T; Ogawa K
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1211-6. PubMed ID: 2112372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system.
    Takahashi Y; Yamashita K; Endo Y; Sasaki T; Mai M
    Surg Today; 2004; 34(10):855-9. PubMed ID: 15449156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
    Arima S; Ohsato K; Hisatsugu T; Shimura H
    Eur J Surg; 1994 Apr; 160(4):227-32. PubMed ID: 8049313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of UFT administered preoperatively in cases of gastric cancer (author's transl)].
    Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Kanbara H; Okajima K; Kurokawa A
    Nihon Gan Chiryo Gakkai Shi; 1981 Dec; 16(7):1417-22. PubMed ID: 6804580
    [No Abstract]   [Full Text] [Related]  

  • 47. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
    Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
    Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of sigmoid colon cancer in a patient undergoing hemodialysis treated by tegafur/uracil/folinate].
    Miyazawa T; Chida T; Hasegawa S; Iwafuchi Y; Kamimura A; Watanabe G
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):149-51. PubMed ID: 18195547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
    Hashimoto T; Arai K; Iwasaki Y; Saze Z; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M; Hiruma K; Yamashita Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):985-8. PubMed ID: 16835493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
    Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
    Konishi T; Idezuki Y; Watanabe H; Haga S; Ushirokouji Y; Shinohara K; Shibusawa M; Bandai Y; Hiraishi M; Murata N; Yabe K; Yamamura T; Yumoto S; Gunji A; Nishigaki M
    Gan To Kagaku Ryoho; 1998 May; 25(6):887-900. PubMed ID: 9617328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
    Yamashita F; Tanaka M; Fukumori K; Ando E; Yano Y; Kato O; Yamamoto H; Fukuda H; Kusaba T; Tanikawa K; Sata M
    Anticancer Drugs; 1998 Jun; 9(5):399-404. PubMed ID: 9660536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics study of UFT in malignant brain tumor patients].
    Harada K; Okamoto H; Kiya K; Fujioka Y; Uozumi T; Kodama Y
    Neurol Med Chir (Tokyo); 1983 Aug; 23(8):619-24. PubMed ID: 6197667
    [No Abstract]   [Full Text] [Related]  

  • 56. Leflunomide and peripheral neuropathy: a potential interaction between uracil/tegafur and leflunomide.
    Kopp HG; Moerike K; Kanz L; Hartmann JT
    Clin Pharmacol Ther; 2005 Jul; 78(1):89-90. PubMed ID: 16003297
    [No Abstract]   [Full Text] [Related]  

  • 57. The University of Texas M.D. Anderson Cancer Center Investigators' Workshop and Consensus Conference on UFT. January 17-18, 1997.
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):11-135. PubMed ID: 9376248
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
    Kobayashi F; Ikeda T; Sakamoto N; Kurosaki M; Tozuka S; Sakamoto S; Fukuma T; Marumo F; Sato C
    Dig Dis Sci; 1995 Nov; 40(11):2434-7. PubMed ID: 7587827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The University of Texas M. D. Anderson Cancer Center Orzel/UFT Investigators' Workshop and Consensus Conference. October 15-18, 1998. Proceedings.
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):15-135. PubMed ID: 10498407
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
    Ikeda K; Kumada H; Arase Y; Nakamura I; Chayama K; Murashima N; Takeuchi K; Nakajima M; Yoshiba A; Irimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2377-85. PubMed ID: 2830421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.